fda approval in myeloma, priority review in all, and 2017 gu cancers symposium highlights
Published 7 years ago • 128 plays • Length 6:27
Download video MP4
Download video MP3
Similar videos
-
11:50
fda approval in myeloma, priority review in dlbcl, application accepted of a biosimilar, and more
-
10:08
fda approvals in myeloma and attp, priority review designations in rcc and hnscc, and more
-
10:49
fda approvals in myeloma, nets, and of a biosimilar, priority review in ovarian cancer, and more
-
8:29
fda approval in multiple myeloma, priority reviews in dlbcl and myeloma, and more
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
-
7:49
fda approval sought in multiple myeloma, 2017 aacr annual meeting highlights, and more
-
10:08
fda approval in waldenstrom macroglobulinemia, priority review and snda in myeloma, and more
-
10:20
fda approvals in myeloma and thyroid cancer, priority review and nda in nsclc, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
11:57
fda approvals of hpv vaccine and ngs assay, priority review in myeloma, and more
-
9:24
fda approvals in myeloma and head and neck cancer, and findings across several tumor types
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
6:02
fda approvals, breakthrough designations, priority reviews, and more
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
9:57
fda approvals in fl and rcc, breakthrough designation in myeloma, and more
-
8:21
fda approval of a biosimilar, priority review in epithelioid sarcoma, and more
-
8:00
fda approval in rcc, european approvals in myeloma and melanoma, and 2016 aua highlights
-
0:31
preview: fda approval in rare leukemias, priority reviews in msi-h cancers and mcc, and more
Clip.africa.com - Privacy-policy